Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
4.850
+0.040 (0.83%)
Nov 22, 2024, 4:00 PM EST - Market closed
Aldeyra Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | -44.8 | -37.54 | -62.02 | -57.78 | -37.55 | -60.83 | Upgrade
|
Depreciation & Amortization | 0.25 | 0.26 | 0.26 | 0.26 | 0.06 | 0.1 | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | - | - | 1.75 | 6.57 | Upgrade
|
Loss (Gain) From Sale of Investments | -1.21 | -0.01 | -0.05 | - | -0.09 | -0.58 | Upgrade
|
Stock-Based Compensation | 5.91 | 5.75 | 8.29 | 7.11 | 7.08 | 8.08 | Upgrade
|
Other Operating Activities | 0.2 | 0.35 | 0.33 | 0.41 | 0.09 | -1.06 | Upgrade
|
Change in Accounts Payable | -0.06 | 1.2 | -0.89 | 0.64 | -0.43 | -2.85 | Upgrade
|
Change in Unearned Revenue | 6 | 6 | - | - | - | - | Upgrade
|
Change in Other Net Operating Assets | 3.02 | -6.34 | -2.56 | 6.8 | -8.4 | 5.59 | Upgrade
|
Operating Cash Flow | -30.67 | -30.33 | -56.64 | -42.56 | -37.49 | -44.98 | Upgrade
|
Capital Expenditures | - | - | -0.02 | -0.01 | - | -0.01 | Upgrade
|
Investment in Securities | -43.35 | 30 | -29.94 | - | 29.02 | 17.88 | Upgrade
|
Other Investing Activities | - | - | - | - | - | 0.61 | Upgrade
|
Investing Cash Flow | -43.35 | 30 | -29.95 | -0.01 | 29.02 | 18.48 | Upgrade
|
Long-Term Debt Issued | - | - | - | - | - | 14.45 | Upgrade
|
Total Debt Issued | - | - | - | - | - | 14.45 | Upgrade
|
Long-Term Debt Repaid | - | -1.04 | - | - | - | - | Upgrade
|
Total Debt Repaid | -1.04 | -1.04 | - | - | - | - | Upgrade
|
Net Debt Issued (Repaid) | -1.04 | -1.04 | - | - | - | 14.45 | Upgrade
|
Issuance of Common Stock | 0.07 | 0.31 | 1.22 | 194.5 | 41.9 | 9.25 | Upgrade
|
Repurchase of Common Stock | - | -0.53 | - | - | - | - | Upgrade
|
Other Financing Activities | -0.22 | - | - | - | - | -0.12 | Upgrade
|
Financing Cash Flow | -1.19 | -1.27 | 1.22 | 194.5 | 41.9 | 23.58 | Upgrade
|
Net Cash Flow | -75.21 | -1.6 | -85.37 | 151.93 | 33.43 | -2.93 | Upgrade
|
Free Cash Flow | -30.67 | -30.33 | -56.65 | -42.56 | -37.49 | -44.99 | Upgrade
|
Free Cash Flow Per Share | -0.52 | -0.51 | -0.97 | -0.79 | -1.10 | -1.66 | Upgrade
|
Cash Interest Paid | 1.77 | 1.7 | 1.34 | 1.34 | 1.39 | 0.24 | Upgrade
|
Levered Free Cash Flow | -57.67 | -27.62 | 92.19 | -123.6 | -20.28 | -7.95 | Upgrade
|
Unlevered Free Cash Flow | -56.44 | -26.32 | 93.25 | -122.51 | -19.09 | -7.57 | Upgrade
|
Change in Net Working Capital | 31.58 | 5.59 | -123.9 | 94.73 | 4.56 | -19.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.